Press release distribution for healthtech and HIPAA

Two things here have no equivalent in the other sectors. Above a threshold — a breach affecting 500 or more residents of a single state — notice to prominent media outlets is required, so the release stops being a marketing decision and becomes a compliance artefact with a deadline and a required content list. And a customer quote from a hospital or clinic is a regulated disclosure, which means the ordinary practice of putting a named user in the second paragraph needs an authorisation behind it.

Healthtech is the only sector in this series where a press release can be a legal obligation rather than a marketing decision, and the only one where the most ordinary element of a release — a customer quote — is a regulated disclosure.

Above a threshold, media notice is compulsory

Two parallel breach regimes apply, depending on which side of the HIPAA line your product sits.

If you are a covered entity or business associate, the HIPAA breach notification rules require notice to individuals, to the Department of Health and Human Services, and — for a breach affecting more than 500 residents of a state or jurisdiction — to prominent media outlets serving that area.

If you are a consumer health app, wearable or personal-health-record vendor that falls outside HIPAA, the FTC's Health Breach Notification Rule reaches you instead. 16 CFR 318.3 requires each vendor of personal health records and each PHR-related entity, following discovery of a breach of unsecured identifiable health information, to notify each affected individual who is a US citizen or resident, to notify the Federal Trade Commission, and to notify prominent media outlets where the breach affects 500 or more residents of a state or jurisdiction.

That last clause has a practical consequence most healthtech founders have never priced: at 500 affected residents in one state, "issue a press release" stops being a communications question. It is worth knowing before the day you need it that a wire's turnaround is 24 to 72 hours on self-serve tiers, that regional and metro circuits exist for exactly this geography-bounded case — PR Newswire's 2024 card prices Metro circuits at $590 per 400 words and other state or local at $460 — and that a breach notice will run long, at $170 to $175 per additional 100 words on those circuits.

None of this is legal advice, and the timing, content and recipients of a breach notice are exactly the thing to have counsel decide. The point here is narrower: distribution is a dependency in your incident-response plan, and buying it under time pressure from a vendor you have not vetted is a bad way to discover that.

A customer quote can be a HIPAA disclosure

Now the everyday case. Healthtech releases quote hospitals, clinics and clinicians, and they carry outcome numbers from deployments. Both are capable of being uses or disclosures of protected health information for marketing.

45 CFR 164.508 requires a covered entity to obtain an authorisation for any use or disclosure of protected health information for marketing, with narrow exceptions for face-to-face communications and promotional gifts of nominal value. If the marketing involves the covered entity receiving financial compensation from a third party, the authorisation must say so.

The shapes this takes in a release:

• A patient testimonial. Almost always requires an individual authorisation, and a signed model release is not the same document.
• A named clinician quote praising your product, where your customer is the clinician's employer and the quote was arranged as part of a commercial agreement. That is the compensation case, and it is your customer's compliance problem before it is yours — which is precisely why a hospital's communications office will take three weeks to approve two sentences.
• Small-denominator outcome numbers. "Reduced readmissions for 11 patients at a named 40-bed facility" is closer to identifiable than it looks. Round up, or aggregate across sites.

The wire will not catch any of this. No newswire in this survey publishes a review step for PHI, and the one health-adjacent rule the wires do apply is aimed elsewhere entirely.

What the wires actually restrict, and why it catches healthtech

The published health rules are about consumer products, not clinical software, but the boundaries are drawn broadly enough to catch healthtech companies on a product line.

• EIN Presswire bans all supplements "irrespective of legality" and accepts pharmacies only conditionally, on prescription status and a US or UK site.
• Newsfile bans unregulated supplements and treatments.
• PRWeb refuses non-compliant pharmaceuticals, unsafe weight-loss products and misleading health supplements, and accepts prescription pharmaceuticals conditionally.

A digital-health company with a nutrition SKU, a metabolic-health app that ships a supplement, or a telehealth platform with a weight-management line can be refused on the whole release rather than the product. The published refusals by category sets out which routes remain, and it is worth reading before you commit to a launch date — at least one vendor states in writing that refunds are not issued when a compliance review fails.

Separately, if your product makes a diagnostic or treatment claim, the question of whether it is a regulated device is upstream of the release entirely. A release is a durable, dated, third-party-hosted copy of the strongest claim you have ever made about your software. Write it at the level your regulatory position supports, not at the level your deck does.

What a release realistically achieves here

Healthtech sells to procurement committees, not to search traffic. That reframes the purchase.

The useful outputs of a syndication buy are a dated public record of an announcement — a funding round, a certification, a partnership, a health-system go-live — and a set of third-party URLs you can cite accurately in a security questionnaire or an RFP response. Those are real. What it does not produce is trade-press coverage in the outlets health-system CIOs actually read, because that press does not ingest wire feeds. The difference between a paid page and an earned one is the entire distinction, and it is invisible on a logo wall.

On links: almost every syndicated press link is nofollow, which is normal rather than a defect. If a vendor is selling you healthtech distribution on a search-authority argument, read why that argument is usually wrong before you buy on it, and check any placement yourself afterwards. Our catalogue prints what we read off each outlet's live page, and "Unconfirmed" against the ones we have not opened.

What we sell, and what we are

We are a reseller. Distribution is bought from wire partners and marked up — the ordinary structure of this market, and worth knowing about any vendor you talk to. Our packages run $599 to $899, and what we add is that we open every published URL and report what actually went live, marked as measured or as supplier-reported.

We do not review copy for HIPAA, FDA or FTC exposure, and no distributor at this price point does. We do not promise rankings, permanent pages, or that any named outlet will publish.

What we could not establish

Business Wire and ACCESS Newswire publish no content policy at all, and Business Wire publishes no rate card. For a breach notice with a statutory clock running, "we will find out from a salesperson whether they take it" is not a plan. If media notice is a live scenario for your company, get a named contact and a written policy answer from a wire now, while nothing is on fire.